Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 33.3% increase over the number of companies inspected in the previous year, when six companies received six inspections.
Most of the companies inspected at the time were involved in the Food and Cosmetics sector. The second most common type of company inspected period worked in the Veterinary, Drugs, and Biologics sectors.
There were seven companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
CHS, Inc. | Food and Cosmetics | 06/27/2024 | No Action Indicated (NAI) |
CHS, Inc. | Food and Cosmetics | 12/16/2024 | No Action Indicated (NAI) |
CHS, Inc. | Food and Cosmetics | 12/17/2024 | No Action Indicated (NAI) |
Cargill, Inc. | Veterinary | 01/17/2024 | No Action Indicated (NAI) |
Dakota Specialty Milling, Inc. | Food and Cosmetics | 01/31/2024 | No Action Indicated (NAI) |
Drayton Foods, LLC | Food and Cosmetics | 07/25/2024 | No Action Indicated (NAI) |
Mama G African Store, LLC | Food and Cosmetics | 09/12/2024 | Voluntary Action Indicated (VAI) |
Michael J. Lillestol, M.D. | Drugs | 02/22/2024 | No Action Indicated (NAI) |
South Dakota Lions Eye & Tissue Bank, Inc. | Biologics | 05/30/2024 | No Action Indicated (NAI) |